Navigation Links
Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
Date:5/1/2008

Company to Provide Financial Guidance for Fiscal 2008 through 2010

PITTSBURGH, May 1 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced today that it will host a conference call and live webcast on Thursday, May 8, 2008, at 5 p.m. ET to provide a review of the first quarter ended March 31, 2008. The company also will provide updated financial guidance for fiscal 2008 through fiscal 2010 and an operational and integration update on Merck Generics, which the company acquired on Oct. 2, 2007. The company will release its financial results after the market closes May 8.

The dial-in number to access the May 8 call is 877-719-9810 or 719-325-4793 for international callers. A replay, available for approximately seven days, will be available at 888-203-1112 or 719-457-0820 for international callers with access pass code 4576196.

To access a live webcast of the May 8 call, please log on to Mylan's Web site (http://www.mylan.com) at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on http://www.mylan.com for approximately seven days.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest-and highest quality-product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information about Mylan, visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Declares Quarterly Preferred Stock Dividend
2. Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
3. Mylan Announces Final FDA Approval for Trandolapril Tablets
4. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
5. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
6. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
7. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
8. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
9. Mylan Restores Availability of Generic Levothyroxine in Florida
10. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
11. Mylan Declares Quarterly Preferred Stock Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... March 30, 2017 , ... According to the American Society of ... putting it among the top 5 most popular minimally-invasive cosmetic procedures in the country. ... will be performed over the next 8-10 weeks. For anyone considering a hair removal ...
(Date:3/30/2017)... NC (PRWEB) , ... March 30, 2017 , ... ... will host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ... 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... women’s professional squash, announced it has enlisted New York City-based sports and entertainment ... will develop and procure sponsorship opportunities for the Professional Squash Association (PSA), which ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, ... Spice", it has been used for thousands of years. , "The West has caught ... of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of ...
(Date:3/29/2017)... Indianapolis, IN (PRWEB) , ... March 29, 2017 ... ... Benefits Study, this webinar provides insight into the challenges employers face in trying ... the complexity of managing employee benefits programs? Adding to the growing complexity, ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... YORK , March 30, 2017  Purcell Julie & ... shareholders nationwide, is investigating a potential breach of fiduciary duty ... (NASDAQ: SGYP ). If you ... obtaining additional information regarding this investigation, free of charge, please ... ...
(Date:3/29/2017)... Wound care devices and products are used ... The industry mainly consists of establishments engaged in manufacturing ... wounds caused by mechanical, chemical, thermal, and radiogenic trauma; ... diabetes, skin related diseases, immunological diseases, and other chronic ... the largest region in the wound care devices market ...
(Date:3/29/2017)... 2017 Global intravenous (IV) iron and oral iron ... growing at a CAGR of 5%. Iron ... to treat anemia or other iron deficiencies. Oral iron supplements ... However, in some cases, oral administrations are not capable of ... iron therapy comes into the picture. Global Intravenous ...
Breaking Medicine Technology: